Singapore Blood Plasma Market – Industry Trends and Forecast to 2026
- DAT3308144
- 100 Pages
- October 2019
- Healthcare
Market Segmentation:
By Type (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Other Plasma Products), Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Other Applications), End User (Hospital, Clinics, Clinical Research Laboratories, Academic Institutes), Country (Singapore, Malaysia and Thailand)
Some of the major factors contributing to the growth of Singapore blood plasma market:
• Growing prevalence of blood plasma disorders
• Increasing geriatric population
• Rising government initiatives
Market Players:
The key market players Singapore blood plasma market are listed below:
• CSL Limited
• Grifols S.A.
• Takeda Pharmaceutical Company Limited
• Octapharma AG
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF SINGAPORE BLOOD PLASMA MARKET
1.4 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 SINGAPORE BLOOD PLASMA MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELING
2.8 PRODUCTS LIFELINE CURVE
2.9 SECONDARY SOURCES
2.10 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING PREVALENCE OF BLOOD PLASMA DISORDERS
3.1.2 INCREASING GERIATRIC POPULATION
3.1.3 RISING DEMAND OF BLOOD PLASMA DERIVATIVES PRODUCTS
3.2 RESTRAINTS
3.2.1 HIGH COST OF PLASMA THERAPY
3.2.2 EASY AVAILABILITY OF RECOMBINANT PLASMA
3.3 OPPORTUNITIES
3.3.1 INCREASING IN AWARENESS ABOUT BLOOD & PLASMA DONATION
3.3.2 TECHNOLOGICAL ADVANCEMENT IN IMMUNOGLOBULIN
3.4 CHALLENGE
3.4.1 STRINGENT REGULATORY REQUIREMENTS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 SINGAPORE BLOOD PLASMA MARKET, BY TYPE
6.1 OVERVIEW
6.2 IMMUNOGLOBULIN
6.2.1 SUBCUTANEOUS IMMUNOGLOBULIN (SCIG)
6.2.2 INTRAVENOUS IMMUNOGLOBULIN (IVIG)
6.2.3 OTHER IMMUNOGLOBULINS
6.3 ALBUMIN
6.4 COAGULATION FACTOR CONCENTRATES
6.4.1 PROTHROMBIN COMPLEX CONCENTRATE
6.4.2 FACTOR XIII
6.4.3 FACTOR VIII
6.4.4 FACTOR IX
6.4.5 FIBRINOGEN CONCENTRATES
6.4.6 VON WILLEBRAND FACTOR
6.5 PROTEASE INHIBITORS
6.6 OTHER PLASMA PRODUCTS
7 SINGAPORE BLOOD PLASMA MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 HEMATOLOGY
7.3 CRITICAL CARE
7.4 IMMUNOLOGY
7.5 PULMONOLOGY
7.6 HEMATO-ONCOLOGY
7.7 RHEUMATOLOGY
7.8 NEUROLOGY
7.9 OTHER APPLICATIONS
8 SINGAPORE BLOOD PLASMA MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 CLINICS
8.4 CLINICAL RESEARCH LABORATORIES
8.5 ACADEMIC INSTITUTES
9 SINGAPORE
9.1 SINGAPORE
10 SINGAPORE BLOOD PLASMA MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: SINGAPORE
11 COMPANY PROFILE
11.1 CSL LIMITED
11.1.1 COMPANY SNAPSHOT
11.1.2 REVENUE ANALYSIS
11.1.3 PRODUCT PORTFOLIO
11.1.4 RECENT DEVELOPMENT
11.2 GRIFOLS, S.A.
11.2.1 COMPANY SNAPSHOT
11.2.2 REVENUE ANALYSIS
11.2.3 PRODUCT PORTFOLIO
11.2.4 RECENT DEVELOPMENT
11.3 TAKEDA PHARMACEUTICAL COMPANY LIMITED
11.3.1 COMPANY SNAPSHOT
11.3.2 REVENUE ANALYSIS
11.3.3 PRODUCT PORTFOLIO
11.3.4 RECENT DEVELOPMENT
11.4 OCTAPHARMA AG
11.4.1 COMPANY SNAPSHOT
11.4.2 REVENUE ANALYSIS
11.4.3 PRODUCT PORTFOLIO
11.4.4 RECENT DEVELOPMENT
12 QUESTIONNAIRE
13 RELATED REPORTS
TABLE 1 POPULATION STATISTICS WITH BLOOD DISORDER
TABLE 2 SINGAPORE BLOOD PLASMA MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 3 SINGAPORE IMMUNOGLOBULIN IN BLOOD PLASMA MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 4 SINGAPORE COAGULATION FACTOR CONCENTRATES IN BLOOD PLASMA MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 5 SINGAPORE BLOOD PLASMA MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 6 SINGAPORE BLOOD PLASMA MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 7 SINGAPORE BLOOD PLASMA MARKET, BY TYPE, 2017 - 2026 (USD MILLION)
TABLE 8 SINGAPORE IMMUNOGLOBULIN IN BLOOD PLASMA MARKET, BY TYPE, 2017 - 2026 (USD MILLION)
TABLE 9 SINGAPORE COAGULATION FACTOR CONCENTRATES IN BLOOD PLASMA MARKET, BY TYPE, 2017 - 2026 (USD MILLION)
TABLE 10 SINGAPORE BLOOD PLASMA MARKET, BY APPLICATION, 2017 - 2026 (USD MILLION)
TABLE 11 SINGAPORE BLOOD PLASMA MARKET, BY END USER, 2017 - 2026 (USD MILLION)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
